NYSE
Pfizer, Inc. (PFE)
♥ 311 Thanks from members
Pfizer (PFE) presents a mixed market sentiment characterized by solid Q2 2026 earnings beats, a strong 6.09% dividend yield, and pipeline developments like early obesity drug PF-08653944, counterbalanced by legal liabilities, patent competition concerns, and divided analyst price targets.